Drug Trial Radar · NCT06312748
Novel Approaches for Improving Vascular Function in Veterans With HFpEF
Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
May 19, 2021
Primary completion
Sep 30, 2028
Study completion Sep 30, 2030
Sponsor
- Lead sponsor
- VA Office of Research and DevelopmentFederal agency
- Sponsor type
- Federal agency
- Collaborators
- University of Utah
- First posted
- Mar 15, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This project will evaluate the impact of L-Citrulline, tetrahydrobiopterin (BH4), and atorvastatin administration on physical capacity and vascular function in Veterans with heart failure with preserved ejection fraction (HFpEF).
Conditions
- Heart Failure With Preserved Ejection Fraction
- Inflammation
Interventions
L-CitrullineDrug
100 mg tablet
Placebo for L-CitrullineDrug
L-Citrulline-matched Placebo tablet
BH4Drug
10mg/kg
Placebo for BH4Drug
BH4-matched Placebo
AtorvastatinDrug
10 mg tablet
Placebo for AtorvastatinDrug
Atorvastatin-matched Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Flow-mediated dilation (FMD)Time frame: Baseline, Day 90
Locations
1 site in 1 country. Site status is shown where the registry gives one.
VA Salt Lake City Health Care System, Salt Lake City, UT
Salt Lake City, Utah · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.